NONMEM Users Network Archive

Hosted by Cognigen

Rosenön Meeting 2009: DMPK Aspects of Drug Combinations

From: Erik Ahlzén <erik.ahlzen>
Date: Fri, 24 Apr 2009 15:45:48 +0200

Rosenn Meeting 2009: DMPK Aspects of Drug Combinations =
<http://www.lakemedelsakademin.se/templates/kurs/kurstillfalle.aspx?kId==
3458&id=3457>

September 17-19, 2009

Stockholm, Sweden

 

This year's meeting will deal with various aspects of drug combinations =
both from a preclinical and clinical point of view. We will discuss =
methods to identify and predict clinical relevant drug-drug =
interactions. We will also look into PK/PD aspects of drug combinations =
as well as pharmacogenetic implications for certain patient groups. In =
addition we will debate regulatory aspects of drug combinations.

 

Speakers

Michel Eichelbaum, Dr. Margarete Fischer-Bosch - IKP, Kim Brouwer, =
University of North Carolina, Heyo Kroemer, Ernst Moritz Arndt =
University of Greifswald, Magnus Ingelman-Sundberg, Karolinska =
Institutet, Johan Gabrielsson, AstraZeneca R&D Mlndal, Kuresh Youdim, =
Pfizer Global R&D, Sandwich, Thomas Bouillon, Novartis Pharma, Ulf =
Diczfalusy, Karolinska University Hospital, Mikko Niemi, University of =
Helsinki, Ylva Bttiger, Karolinska University Hospital, Erik =
Eliasson, Karolinska University Hospital, Filip Josephson, Karolinska =
University Hospital, Qun-Ying Yue, The Medical Products Agency, Monica =
Edholm, The Medical Products Agency, Gustav Ahlin, Uppsala University, =
Urban Fagerholm, AstraZeneca R&D Sdertlje

 

More speakers will be announced soon!

Please visit www.swepharm.se/Rosenon2009 to see the preliminary program

 

Welcome!

 

 

Erik Ahlzn, Project Manager
The Swedish Academy of Pharmaceutical Sciences
erik.ahlzen

 

 

 

 


Received on Fri Apr 24 2009 - 09:45:48 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to: nmusers-request@iconplc.com.

Once subscribed, you may contribute to the discussion by emailing: nmusers@globomaxnm.com.